OncoMed: Clinical Trial Update (OncoMed) - Jul 17, 2015 - “Manageable safety profile, Diarrhea is most common on-target toxicity”; “Single-agent Ph 2 dose of 1.5 mg/kg Q3W”; “Plasma half-life of 1.5 days”; “Encouraging early signs of anti-tumor activity in Notch1 ICD-high patients”
P1 data • Oncology
|